“Luck is what happens when talent meets opportunity.“
In March 2017 someone knocked on the door of Innate: he was an entrepreneur who wanted to acquire the Novi Ligure company. Federico Panzieri turned down the offer but realised the potential for growth with a strong partner at his side. A new company was formed: InnPharm Srl of which Innate holds a 49% share together with Pharmaceutica (49%) and a private individual (2%). Panzieria said: “It is a winning policy for SMEs to create synergy: together we have over one hundred resources and a turnover of 60 million.”. Innate opened itself to the foreign markets of Eastern Europe and Asia; the union of several players of the same chain created economies of scale, greater commercial strength, and synergies of production and sale.